We provide a comprehensive GPCR catalog covering 550 receptors, including 300 human and 250 mouse GPCRs. Using our proprietary high-sensitivity assay technology, receptor activity can be evaluated in a unified format, supporting panel assays, dose-response studies, and a wide range of functional analyses. Our platform enables comprehensive characterization, including orphan GPCRs. Click below for details or contact us for information about GPCRs of other animal species such as rats, rabbits, dogs, and macaque monkeys.
Filters Sort results
Reset Apply
Species | Receptor | Family | Assays | |
|---|---|---|---|---|
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 13 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 4.0 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 2.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 3.2 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 3.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.9 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 2.5 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 26 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 85 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 8.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: serotonin EC50: 1.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 310 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 110 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 31 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 47 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: carbachol EC50: 5.9 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 4.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 11 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 19 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NECA EC50: 1.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 18 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 28 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: L‐phenylephrine EC50: 67 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 71 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 33 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: noradrenaline EC50: 89 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 22 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 26 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: isoproterenol EC50: 47 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: angiotensin ⅠⅠ EC50: 920 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: apelin‐13 EC50: 8.1 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: TGR5 agonist EC50: 350 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: bombesin EC50: 2.4 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: GRP EC50: 1.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: NMB EC50: 590 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: calcitonin EC50: 2.7 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CGRP EC50: 1.0 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: cinacalcet EC50: 140 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CP55940 EC50: 640 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CP55940 EC50: 2.6 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: LPI EC50: 1.2 µM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: N‐oleoylethanolamine EC50: 6.3 µM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: chemerin EC50: 15 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL3 EC50: 250 pM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL2 EC50: 1.3 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL22 EC50: 20 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL4 EC50: 7.1 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL20 EC50: 3.8 nM | ||
| Human | Available Assay modes: - Panels: |  Reference agonist: CCL21 EC50: 15 nM |
Contact Us
We welcome quotation requests and inquiries about our assay services, custom assay development, or co-development opportunities. Visit Contact Us for the ordering process and the inquiry form. Our team will respond within 24 hours.